UPSTREAM CONSULTING, INC.

Lobbying for RARE ACCESS ACTION PROJECT · reimbursement for rare disease patient care.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate · $15,000.00 income · posted Jan 30, 2026

Lobbying activity 1

Medicare/Medicaid

Protect Orphan Drug incentives.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem